Ligand validation:1YQN

GPP: GERANYL DIPHOSPHATE

GPP is a Ligand Of Interest in 1YQN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1YQN_GPP_A_300	1%	49%	0.52	0.631	0.51	1.45	-	3	0	0	100%	0.33
3ESJ_GPP_A_904	42%	35%	0.219	0.938	1.08	1.49	2	4	14	0	100%	0.6121
3ERN_GPP_B_901	31%	15%	0.207	0.877	2.19	1.64	6	6	3	0	100%	1
3ELC_GPP_C_904	16%	14%	0.275	0.849	2.29	1.59	7	4	2	0	100%	1
3EOR_GPP_A_902	15%	1%	0.3	0.867	3.52	4.21	11	9	3	0	100%	0.33
2GZL_GPP_A_903	4%	18%	0.4	0.794	2.03	1.54	5	4	0	0	100%	0.33
2VG3_GPP_B_1298	100%	7%	0.05	0.994	2.78	2.12	3	5	0	0	100%	1
4K7T_GPP_A_101	97%	51%	0.069	0.985	0.87	1.02	1	-	0	0	100%	1
8A78_GPP_A_505	95%	67%	0.069	0.971	0.58	0.7	-	-	1	0	100%	1
8A73_GPP_A_505	93%	67%	0.075	0.971	0.56	0.71	-	-	0	0	100%	1
6PGN_GPP_A_402	91%	55%	0.085	0.973	0.68	1.04	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.